Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China · Delayed Price · Currency is CNY 30.60
-0.04 (-0.13%)
Jul 31, 2026, 3:00 PM CST
SHA:603392 Market Cap
SHA:603392 has a market cap or net worth of 38.69 billion as of July 31, 2026. Its market cap has decreased by -47.92% in one year.
Market Cap
38.69B
Enterprise Value
34.90B
Revenue
1.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.60
ChartMarket Cap Chart
Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 38.69B, an increase of 608.18%. That is a compound annual growth rate of 36.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 38.69B | -31.91% |
| Dec 31, 2025 | 56.82B | -36.26% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 66.61B |
| Pharmaron Beijing | 60.17B |
| Shanghai Allist Pharmaceuticals | 52.00B |
| Asymchem Laboratories (Tianjin) | 51.02B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 35.29B |
| Shanghai RAAS Blood Products | 34.41B |
| Suzhou Zelgen Biopharmaceuticals | 31.08B |
| Chongqing Zhifei Biological Products | 30.88B |